A federal judge has granted partial class certification to participants in Merck & Co. Inc. retirement plans who say they lost money because the company inflated its stock price by downplaying known health risks of its painkiller Vioxx.
The plaintiffs are participants in or beneficiaries of four retirement plans between Oct. 1, 1998, and Sept. 30, 2004, and whose accounts invested in Merck stock, which lost more than $37 million in the first month of the drug’s withdrawal in 2004 after it was linked to cardiovascular problems.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
